General Information
Get notified when Cerevance moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Cerevance
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
AI Insight
Bounce Watch AICerevance recently secured a Series C funding round while simultaneously completing patient enrollment for its pivotal Phase 3 ARISE trial across the U.S., Europe, the UK, and Australia. This significant clinical and geographical expansion, coupled with the CEO's active participation in neuroscience thought leadership, signals the company's rapid acceleration towards advanced pipeline development and potential market entry. These developments collectively underscore Cerevance's strategic advancement in de-risking its neurodegenerative therapies.
About Cerevance
Taxonomy: neuroscience, pharmaceuticals, mental health, drug discovery, neurological disorders, brain research, psychiatric diseases, biopharmaceuticals, genomics, neurodegenerative diseases
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | •••••• | 7 |
|
01 May 2026 |
| Series B | •••••• | 8 |
|
01 Apr 2024 |
| Series B | •••••• | 8 |
|
01 Feb 2023 |
| Series B | •••••• | 8 |
|
01 Jul 2020 |
| Series B | •••••• | 5 |
|
01 Apr 2020 |
Cerevance Alternatives & Competitors
Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic...
A leading CRO with unparalleled expertise in intricate cell biology, focusing on human neurodegenera...
FAQ About Cerevance
Don't just browse. Track.
Signal Tracker monitors Cerevance and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.